Penetration of vancomycin into mediastinal and cardiac tissues in humans | Zendy

C. Martín | Zendy; M. Alaya | Zendy; M N Mallet | Zendy; X. Viviand | Zendy; K Ennabli | Zendy; R. Said | Zendy; P. De Micco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Penetration of vancomycin into mediastinal and cardiac tissues in humans

Author(s) -

C. Martín,

M. Alaya,

M N Mallet,

X. Viviand,

K Ennabli,

R. Said,

P. De Micco

Publication year - 1994

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.38.2.396

Subject(s) - vancomycin , staphylococcus aureus , staphylococcus epidermidis , pericardium , medicine , cardiopulmonary bypass , penetration (warfare) , staphylococcal infections , anesthesia , surgery , biology , bacteria , operations research , engineering , genetics

Vancomycin penetration into heart tissues (valves, myocardium, auricles, and pericardium) and mediastinal tissues (fat and sternal bone) was evaluated after two regimens of vancomycin administration. Ten patients were given 15 mg of vancomycin per kg of body weight before anesthesia. Ten other patients received the same dose and then a second 7.5-mg/kg dose at the time of initiation of cardiopulmonary bypass. Similar and satisfactory vancomycin tissue penetrations were observed in both groups. However, for some patients in the two groups, vancomycin levels in tissue were less than the MICs for potential pathogens (Staphylococcus aureus and Staphylococcus epidermidis).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research